A Pill Might Control Pancreatic Cancer, Even If It Doesn't Cure It  
9/11/2017 6:53:10 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
A new type of cancer medication, called PARP inhibitors, is gaining traction in clinical practice. Already the FDA has approved several drugs in this class: Lynparza (olaparib, AstraZeneca), Rubraca (rucaparib, Clovis), and Zejula (niraparib, Tesaro). So far, these pills are approved only for women with particular genetic findings, and mainly for ovarian cancer and related tumors, such as Fallopian tube cancer.